English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biomarin Pharmaceuticals
Carol Ostrow
| Dec 28, 2017
BioMarin presents revised clinical data for hemophilia A treatment
Ruth de Jauregui
| Jun 8, 2017
BioMarin's Brineura gets European approval for treating CLN2 brain disease in children
Chandra Lye
| May 4, 2017
Drug offers hope for children with rare brain disease
Caitlin Nordahl
| Apr 24, 2017
BioMarin, Par reach settlement on Kuvan
Jeff Gantt
| Dec 18, 2016
BioMarin Pharmaceutical initiates phase 3 vosoritide trial
Amanda Rupp
| May 11, 2016
BioMarin releases EMA grants for Batten disease treatment
Trending
+
Pharmaceuticals
Patient Daily
| Dec 17, 2024
Lung association warns against combined risks of smoking and radon
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
Discovery of replication hubs may lead to new antiviral therapies for norovirus
Patient Daily
| Dec 23, 2024
Patient Advocacy Group: ‘Policymakers must remove barriers to the development and delivery of innovative’ health care
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
California student returns home after receiving life-saving heart transplant
